MiR-198 bound to the 3′ UTR of c-Met mRNA and blocked p44/42 MAPK activity through HGF/c-Met pathway, leading to the inhibition to migration and invasion of HCC cells (Tan et al., 2011). The gene discussed is MET; the disease is hepatocellular carcinoma.